ArticleBMC neurology2026
Epidemiologic and clinical features of Alzheimer's disease: a hospital study based on the memory clinic in Abidjan, Côte D'ivoire, Sub-Saharan Africa.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a retrospective 4 year, cross-sectional hospital based study describing the main epidemiological and clinical characteristics in a cohort of 36 patients with Alzheimer’s disease. The AD patients were identified out of a series of 295 patients attending a Specialized Memory clinic. The main epidemiolocal findings were a mean time to consultation of 3.3 years, equal M/F sex ratio, mean age 70.5 years, ≥ 65 years 72.3%, and had a higher overall level of education 52%. The main clinical findings as assessed by a Mean Montreal Cognitive Assessment score of 10.9, report a mean loss of memory capacity of 89.2%, loss of visuospatial and executive functions of 64% and of attention of 61.5%. The main radiological finding on MRI investigation was bilateral hippocampal atrophy (63.9%) with radiologic lesions significantly more pronounced in the elderly than in the young. On univariate analysis, moderate Alzheimer’s disease was associated with age < 75 years, higher education and cortical atrophy. A history of diabetes and cortico-subcortical atrophy were associated with severe AD. In conclusion, this study provides an initial database on this disease in Côte d’Ivoire, but also enriches the existing database in sub-Saharan Africa. The authors state that the main findings of the study are similar to those described in the literature. However, they note the predominance in young subjects < 65 years old (27.7%) and the strong association with higher education (university) of 52%. Furthermore, the authors highlight a diagnostic delay and difficulties in diagnostic management related to the costs of paraclinical investigations for this disease. Government interventions to better characterize this disease using larger sample sizes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.